Home > Financial Ratios > BROOKS LABORATORIES

BROOKS LABORATORIES
Core EBITDA Margin

    Back to All Ratios
BROOKS LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BROOKS LABORATORIES
Please provide your vote to see the results

BROOKS LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 1.623.86-41.80-15.630.67

What is the latest Core EBITDA Margin ratio of BROOKS LABORATORIES ?

The latest Core EBITDA Margin ratio of BROOKS LABORATORIES is 1.62 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar20251.62
Mar20243.86
Mar2023-41.80
Mar2022-15.63
Mar20210.67

How is Core EBITDA Margin of BROOKS LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2025 1.62
-58.03
Mar2024 3.86
Positive
Mar2023 -41.8
Negative
Mar2022 -15.63
Negative
Mar2021 0.67 -

Other Financial Ratios of BROOKS LABORATORIES


Compare Core EBITDA Margin ratio of peers of BROOKS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BROOKS LABORATORIES ₹201.7 Cr -4.8% -29.3% -62% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,541.0 Cr -3.6% -6.8% -5.6% Stock Analytics
DIVIS LABORATORIES ₹163,031.0 Cr -5.4% -2.4% 3.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,451.0 Cr 3.6% 8.5% 23.5% Stock Analytics
CIPLA ₹112,377.0 Cr -5.1% -7.1% -3.5% Stock Analytics
DR REDDYS LABORATORIES ₹97,355.5 Cr -4.1% -8.3% -12.1% Stock Analytics


BROOKS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BROOKS LABORATORIES

-4.8%

-29.3%

-62%

SENSEX

-0.4%

-1.7%

9.1%


You may also like the below Video Courses